Draft Guidance for Industry on Internet/Social Media Platforms: Correcting Independent Third-Party Misinformation About Prescription Drugs and Medical Devices; Availability: https://www.federalregister.gov/articles/2014/06/18/2014-14221/draft-guidance-for-industry-on-internetsocial-media-platforms-correcting-independent-third-party
The FDA has released new guidelines for how social media is used in healthcare. The University of Michigan had been involved in commenting on the original call for comments on this topic, and emphasized the potential impact of any guidelines on professional medical education and healthcare education more broadly. Those comments are available here
FDA-2009-N-0441 Docket Comments, University of Michigan Public Forum: http://www.slideshare.net/umhealthscienceslibraries/fda2009n0441-docket-comments-university-of-michigan-public-forum
Recent reviewers commenting on the new policy are encouraging people to consider these guidelines in the context of FDA actions, such as recent warning letters that explicitly comment upon Facebook “likes.”
FDA: Warning Letters: 2014: Zarbee’s, Inc. 6/27/14: http://www.fda.gov/iceci/enforcementactions/warningletters/2014/ucm403255.htm
Remember, these are not yet cast in stone, as we are in a period of time when it is still possible to file comments on the docket for the guidelines. How could this impact on your work? How you teach students? Clinical trial recruitment? How you connect with patients, or patients connect with you? What about the impact on uses of social media for shaping future policy and grant funding? Even if you are not currently using social media, what about the future and how it might be used?
You can read more, find more links, and information on how to comment at this blogpost by THL Emerging Technologies Informationist, Patricia Anderson.
FDA On Social Media: Time to Pay Attention, Take Two http://etechlib.wordpress.com/2014/08/01/fda-on-social-media-time-to-pay-attention-take-two/